Thụy Sĩ - Tiếng Đức - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 850 mg, sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50 mg, povidonum k 30, natrii laurilsulfas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: hypromellosum, hydroxypropylcellulosum, triethylis citras, e 171, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 2.99 mg. - orales antidiabetikum - synthetika

Thụy Sĩ - Tiếng Đức - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 1000 mg, sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50 mg, povidonum k 30, natrii laurilsulfas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: hypromellosum, hydroxypropylcellulosum, triethylis citras, e 171, talcum, e 172 (rubrum), e 172 (flavum), pro compresso obducto corresp. natrium 3.5 mg. - orales antidiabetikum - synthetika

Thụy Sĩ - Tiếng Đức - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.027 mg. - diabetes mellitus typ 2 - synthetika

Thụy Sĩ - Tiếng Đức - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 850 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: lactosum monohydricum 13.7 mg, e 171, hypromellosum, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 1.7239 mg. - diabetes mellitus typ 2 - synthetika

Thụy Sĩ - Tiếng Đức - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 1000 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (nigrum), e 172 (rubrum), pro compresso obducto corresp. natrium 2.054 mg. - diabetes mellitus typ 2 - synthetika

Đức - Tiếng Đức - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

089pharm gmbh (1011260) - sitagliptinhydrochlorid 1 h<2>o; metforminhydrochlorid - filmtablette - 50 mg/850 mg - sitagliptinhydrochlorid 1 h<2>o (43765) 56,69 milligramm; metforminhydrochlorid (6150) 850 milligramm

Đức - Tiếng Đức - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

heumann pharma gmbh & co. generica kg (8120809) - sitagliptinhydrochlorid 1 h<2>o; metforminhydrochlorid - filmtablette - 50 mg/850 mg - sitagliptinhydrochlorid 1 h<2>o (43765) 56,687 milligramm; metforminhydrochlorid (06150) 850 milligramm

Đức - Tiếng Đức - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

089pharm gmbh (1011260) - sitagliptinhydrochlorid 1 h<2>o; metforminhydrochlorid - filmtablette - 50 mg/1000 mg - sitagliptinhydrochlorid 1 h<2>o (43765) 56,69 milligramm; metforminhydrochlorid (6150) 1000 milligramm

Đức - Tiếng Đức - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

heumann pharma gmbh & co. generica kg (8120809) - sitagliptinhydrochlorid 1 h<2>o; metforminhydrochlorid - filmtablette - 50 mg/1000 mg - sitagliptinhydrochlorid 1 h<2>o (43765) 56,687 milligramm; metforminhydrochlorid (6150) 1000 milligramm

Liên Minh Châu Âu - Tiếng Đức - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.